A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2019
Price : $35 *
At a glance
- Drugs ID 1201 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Il Dong
- 03 Jun 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 12 Dec 2017 New trial record